ZEB1 and prostate carcinoma: The goal of these studies was to assess whether androgen receptor (AR) directly regulates tcf8. This question is particularly relevant as ZEB1 expression is high in aggressive prostate cancer (PCa) cell lines and tissues and as it promotes phenotypic changes consistent with epithelial to mesenchymal transitions (EMT) in those lines [26, 31].